Information Provided By:
Fly News Breaks for October 14, 2015
STJ, HTWR
Oct 14, 2015 | 05:21 EDT
Goldman Sachs analyst David Roman upgraded HeartWare (HTWR) to Neutral saying the risk/reward is more balanced following the 57% pullback in shares since September 1. Roman sees the potential for a takeover with the company's market capitalization down to $609M and recent consolidation in the MedTech space. He cut his price target for shares to $42 from $67. The analyst also raised his estimates for St. Jude Medical (STJ) to account for the company's recent acquisition of HeartWare peer Thoratec. He maintains a Neutral rating on the stock but upped his price target for shares to $74 from $73.
News For HTWR;STJ From the Last 2 Days
There are no results for your query HTWR;STJ